Cargando…
COVID-19 fulminant myocarditis recovered with veno-arterial extracorporeal membrane oxygenation and Impella CP
A 38-year-old man without a history of coronavirus disease 2019 (COVID-19) vaccination presented with dyspnea and fever. Polymerase chain reaction nasopharyngeal swab for severe acute respiratory syndrome coronavirus 2 was positive. Electrocardiogram showed diffuse ST-segment elevation, and chest ra...
Autores principales: | Matsushita, Shunsuke, Tada, Takeshi, Sasaki, Wataru, Osakada, Kohei, Kawase, Yuichi, Kadota, Kazushige |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese College of Cardiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169577/ https://www.ncbi.nlm.nih.gov/pubmed/37361643 http://dx.doi.org/10.1016/j.jccase.2023.05.003 |
Ejemplares similares
-
Fulminant Myocarditis Managed by Extracorporeal Life Support (Impella® CP): A Rare Case
por: Fox, Henrik, et al.
Publicado: (2017) -
Concomitant use of veno-arterial extracorporeal membrane oxygenation and Impella in the intensive care unit: a case report of fulminant myocarditis with multi-organ failure
por: Gawda, Ryszard, et al.
Publicado: (2020) -
Veno-Arterial Extracorporeal Membrane Oxygenation in Patients with Fulminant Myocarditis: A Review of Contemporary Literature
por: Venkataraman, Shreyas, et al.
Publicado: (2022) -
Veno-arterial extracorporeal membrane oxygenation for severe fever with thrombocytopenia syndrome with fulminant myocarditis: a case report
por: Kim, Uh. Jin, et al.
Publicado: (2021) -
Successful cases of percutaneous left ventricular assist device “Impella” to fulminant myocarditis
por: Hori, Takayuki, et al.
Publicado: (2022)